retatrutide triple hormone receptor agonist metabolic for dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide: A Triple Agonist Shaping
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7




















